Differential Factors for Predicting Outcomes in Left Main versus Non-Left Main Coronary Bifurcation Stenting
Authors
Jung-Joon Cha ; Soon Jun Hong ; Hyung Joon Joo ; Jae Hyoung Park ; Cheol Woong Yu ; Tae Hoon Ahn ; Hyo-Soo Kim ; Woo Jung Chun ; Seung-Ho Hur ; Seung Hwan Han ; Seung-Woon Rha ; In-Ho Chae ; Jin-Ok Jeong ; Jung Ho Heo ; Junghan Yoon ; Ki Hong Choi ; Young Bin Song ; Hyeon-Cheol Gwon ; Jong-Seon Park ; Myeong-Ki Hong ; Joon-Hyung Doh ; Kwang Soo Cha ; Doo-Il Kim ; Sang Yeub Lee ; Kiyuk Chang ; Byung-Hee Hwang ; So-Yeon Choi ; Myung Ho Jeong ; Chang-Wook Nam ; Bon-Kwon Koo ; Do-Sun Lim
Citation
JOURNAL OF CLINICAL MEDICINE, Vol.10(14) : 3024, 2021-07
Background: No large-scale study has compared the clinical and angiographic predictors of cardiovascular events in patients with left main bifurcation (LMB) and non-LMB stenting after second-generation DES implantation. Herein, we investigated differential clinical and angiographic factors for predicting outcomes in LMB versus non-LMB stenting.
Methods: A total of 2648 patients with bifurcation lesions treated with second-generation DESs from the retrospective patient cohort were divided into an LMB group (n = 935) and a non-LMB group (n = 1713). The primary outcome was the 7-year incidence of target lesion failure (TLF), defined as the composite of cardiac death, myocardial infarction, and target lesion revascularization.
Results: The incidence of TLF was 9.8%. Those in the LMB group were associated with a higher risk of TLF (14.2% versus 7.5%, p < 0.001) than those in the non-LMB group. Regarding the LMB group, independent predictors of TLF were chronic kidney disease (CKD), reduced left ventricular ejection fraction (LVEF), and two-stenting. Regarding the non-LMB group, CKD, reduced LVEF, old age, diabetes, and small diameter of the main vessel stent were independent predictors of TLF.
Conclusions: The two-stent strategy could potentially increase TLF for the LMB lesions, and achieving the maximal diameter of the main vessel stent could result in better clinical outcomes for non-LMB lesions.